UY25070A1 - Formas de dosificación de solución encapsulada de sertralina - Google Patents
Formas de dosificación de solución encapsulada de sertralinaInfo
- Publication number
- UY25070A1 UY25070A1 UY25070A UY25070A UY25070A1 UY 25070 A1 UY25070 A1 UY 25070A1 UY 25070 A UY25070 A UY 25070A UY 25070 A UY25070 A UY 25070A UY 25070 A1 UY25070 A1 UY 25070A1
- Authority
- UY
- Uruguay
- Prior art keywords
- sertraline
- disorders
- dosage forms
- dosage
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Forma de dosificación que comprende una composición encapsulada de gelatina que comprende sertralina o una sal farmacéuticamente aceptable de la misma y un vehículo inmiscible con agua (como un mono, di o triglicérido, o un agente vegetal), la cual reduce el tiempo en el que se consigue la concentración máxima de sertralina en el plasma de 0,5 horas, con respecto al tempo máximo obtenido por medio de una forma de dosificación de sertralina liberación inmediata. Se incluyen formas de dosificación particulares, por ejemplo: que contiene 10mgA a 250 mgA de sertralina; como también aquellas composiciones donde el vehículo coprende un tensioactivo o emulsionante; al igual que la dosificación que comprende un éster líquido de un alcohol de cadena corta y un ácido, como por ejemplo ésteres de propilenglicol de los ácidos caprílico y/o cáprico. Esta invención es útil para tratar enfermedades psiquiátricas y enfermedades afines, en particular trastornos obsesivos-compulsivos, trastornos de estrés post-traumáticos, y trastornos relacionados con la ansiedad y el pánico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5140197P | 1997-07-01 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY25070A1 true UY25070A1 (es) | 2000-12-29 |
Family
ID=21971076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY25070A UY25070A1 (es) | 1997-07-01 | 1998-06-29 | Formas de dosificación de solución encapsulada de sertralina |
Country Status (40)
| Country | Link |
|---|---|
| EP (1) | EP0980241B1 (es) |
| JP (1) | JP3585245B2 (es) |
| KR (1) | KR100371730B1 (es) |
| CN (1) | CN1261792A (es) |
| AP (1) | AP945A (es) |
| AR (1) | AR015916A1 (es) |
| AT (1) | ATE256457T1 (es) |
| AU (1) | AU724635B2 (es) |
| BG (1) | BG103917A (es) |
| BR (1) | BR9809712A (es) |
| CA (1) | CA2290973C (es) |
| CO (1) | CO4940405A1 (es) |
| DE (1) | DE69820608T2 (es) |
| DK (1) | DK0980241T3 (es) |
| DZ (1) | DZ2544A1 (es) |
| EA (1) | EA001905B1 (es) |
| ES (1) | ES2210760T3 (es) |
| GT (1) | GT199800090A (es) |
| HR (1) | HRP980378B1 (es) |
| HU (1) | HUP0002250A3 (es) |
| ID (1) | ID24673A (es) |
| IL (1) | IL133075A0 (es) |
| IS (1) | IS5266A (es) |
| MA (1) | MA24586A1 (es) |
| MY (1) | MY119728A (es) |
| NO (1) | NO996492L (es) |
| NZ (1) | NZ501252A (es) |
| OA (1) | OA11246A (es) |
| PA (1) | PA8454001A1 (es) |
| PE (1) | PE97299A1 (es) |
| PL (1) | PL337807A1 (es) |
| PT (1) | PT980241E (es) |
| SK (1) | SK282914B6 (es) |
| TN (1) | TNSN98123A1 (es) |
| TR (1) | TR199903282T2 (es) |
| TW (1) | TW382597B (es) |
| UA (1) | UA68350C2 (es) |
| UY (1) | UY25070A1 (es) |
| WO (1) | WO1999001113A1 (es) |
| ZA (1) | ZA985709B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6727283B2 (en) | 1998-10-13 | 2004-04-27 | Pfizer Inc. | Sertraline oral concentrate |
| EE04868B1 (et) * | 1998-10-13 | 2007-08-15 | Pfizer Products Inc. | Farmatseutiline kompositsioon, mis sisaldab vett mittesisaldavat, vedelat kontsentraati oraalseks manustamiseks, mis sisaldab sertraliini v?i selle farmatseutiliselt vastuv?etava soola kogust ning hte v?i rohkemat vett mittesisaldavat farmatseutilis |
| UA75580C2 (uk) | 1999-09-03 | 2006-05-15 | Апбі Холдінгс, Ллк | Застосування дапоксетину або його фармацевтично прийнятної солі в лікарському засобі для лікування розладу статевої функції та промисловий виріб для його застосування |
| CA2420535A1 (en) | 2000-08-30 | 2002-03-07 | Mary Tanya Am Ende | Sustained release formulations for growth hormone secretagogues |
| EP1375659A1 (en) * | 2002-06-18 | 2004-01-02 | Laboratorio di Diagnostica Moleculare | Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions |
| US20040142040A1 (en) * | 2002-10-31 | 2004-07-22 | Dong Liang C. | Formulation and dosage form providing increased bioavailability of hydrophobic drugs |
| WO2016020936A2 (en) * | 2014-07-21 | 2016-02-11 | Patel Jayendrakumar Dasharathlal | A novel oral gastroretentive pharmaceutical dosage form |
| CN108014087A (zh) * | 2017-12-27 | 2018-05-11 | 江苏联环药业股份有限公司 | 一种盐酸舍曲林胶囊的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2197554A1 (en) * | 1994-09-19 | 1996-03-28 | The Du Pont Merck Pharmaceutical Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| DK0768083T3 (da) * | 1995-07-17 | 2003-06-23 | Pfizer | Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt |
-
1998
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 EP EP98923021A patent/EP0980241B1/en not_active Expired - Lifetime
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/en not_active Application Discontinuation
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 CA CA002290973A patent/CA2290973C/en not_active Expired - Fee Related
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active IP Right Cessation
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/xx active
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
-
1999
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5431924A (en) | Anti-inflammatory composition derived from emu oil | |
| AR007536A1 (es) | Una composicion de escamas de aditivo para distribuir un agente de beneficio, un procedimiento para formarla, una composicion de barra detocador moldeada por extrusion que la comprende, y un metodo de aumento de la deposicion del agente de beneficio desde una composicion de barra. | |
| AR012671A1 (es) | Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos | |
| BR9813177A (pt) | Agentes de limpeza para mãos toleráveis para a pele, especialmente agentes de limpeza grossos para mãos | |
| ATE308980T1 (de) | Aus bienenwachs erhaltene aliphatische primäre alkohole mit hohem molekulargewicht und deren pharmazeutische verwendung | |
| ES2183629T3 (es) | Composicion detergente. | |
| EP1419768A4 (en) | COMPOSITIONS FOR PREVENTING OR PREVENTING CONDITIONS OR ILLNESSES CAUSED BY BRAIN SUB-FUNCTIONING | |
| BR9509530A (pt) | Composições farmacêuticas | |
| CO4910124A1 (es) | Composiciones liquidas para el aseo personal que contienen un agnete lipofilo humectante de la piel compuesto de goti- tas relativamente grandes | |
| ATE292460T1 (de) | Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels | |
| UY25070A1 (es) | Formas de dosificación de solución encapsulada de sertralina | |
| BR0112337A (pt) | Derivados de fosfolipìdeos de ácido valpróico e suas misturas | |
| BR0211590A (pt) | Composições de barra de limpeza | |
| CO5160296A1 (es) | Nuevas formas de presentacion para agentes activos labiles en medio acido, unidad de agente activo y proceso para la produccion de dicha unidad de agente | |
| ES2150004T3 (es) | Procedimiento de estabilizacion de los acidos grasos poliinsaturados y utilizacion de estos productos estabilizados en terapeutica y en cosmetologia. | |
| CA1321207C (en) | Cosmetic composition | |
| ES2175671T3 (es) | Agente para el cuidado de la piel. | |
| US6696490B2 (en) | Slow release insect repellent compounds and process for delivering active | |
| KR20160061875A (ko) | 피부 세정제 조성물 | |
| AR034168A1 (es) | Una celobiosa acilada, un metodo para prepararla, un metodo para espesar o estructurar un liquido inmiscible en agua para formar una crema, un solido blando o un solido, una composicion de crema, solido blando o solido, y uso cosmetico de dicha composicion | |
| EA200500659A1 (ru) | Способ получения кардиолипина или его аналога (варианты) и содержащей их липосомы, способы использования кардиолипина или его аналогов в лечении болезней (варианты) и содержащая их композиция (варианты) и ее применение | |
| KR20080064468A (ko) | 미세하고 지속적인 거품을 자체 형성하는 수성 세안제조성물 | |
| ES2562402T3 (es) | Derivados alquilados del p-mentan-3-ol y su utilización como agentes refrescantes | |
| ES2129135T3 (es) | Composiciones limpiadoras que contienen un alcanoato como acondicionador. | |
| JP2551471B2 (ja) | グリセリルエーテル誘導体及びそれを含有する皮膚外用剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VENC | Patent expired |
Effective date: 20180629 |